First-in-human experience with GRPR antagonist [68Ga]Ga-NOTA-PEG2-RM26 in prostate and breast cancer patients using PET/CT

• Annie Bjäreback,
• Olof Jonmarker,
• Antonios Tzortzakakis,
• Emma Jussing,
• Chunde Li,
• Renske Altena,
• Cecilia Hindorf,
• Anna Orlova,
• Rimma Axelsson,
• Thuy A. Tran

Affiliations

Annie Bjäreback

Department of Nuclear Medicine and Medical Physics, Section Nuclear Medicine Huddinge, Karolinska University Hospital

Olof Jonmarker

Division of Radiology, Department for Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet

Antonios Tzortzakakis

Department of Nuclear Medicine and Medical Physics, Section Nuclear Medicine Huddinge, Karolinska University Hospital

Emma Jussing

Department of Oncology-Pathology, Karolinska Institutet

Chunde Li

Department of Oncology

Renske Altena

Department of Oncology-Pathology, Karolinska Institutet

Cecilia Hindorf

Department of Molecular Medicine and Surgery, Karolinska Institutet

Anna Orlova

Department of Medicinal Chemistry, Uppsala University

Rimma Axelsson

Department of Molecular Medicine and Surgery, Karolinska Institutet

Thuy A. Tran

Department of Oncology-Pathology, Karolinska Institutet